Press release
Postoperative Pain Market to Expand at a Significant Growth Rate During the Study Period (2019-32) - Estimates DelveInsight | Concentric Analgesics, Oculis, Vivozon, Haisco, Nevakar, LipoCure, Bexson, SiteOne Therapeutics, InSitu Biologics
Key players such as Oculis (OCS-01), Formosa Pharmaceuticals (APP13007), Taiwan Liposome Company (TLC590), Salvat Laboratories (SVT-15473), and others are evaluating their lead candidates in different stages of clinical development, respectively.
DelveInsight's "Postoperative Pain Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Postoperative Pain Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).
The market report covers emerging drugs, treatment practices, market share of individual Postoperative Pain therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Postoperative Pain treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.
Postoperative Pain: An Overview
Postoperative pain is an anticipated and temporary increase in background pain that occurs following surgical procedures. It is a type of pain that typically lasts less than a few days to months or pain directly related to soft tissue damage such as a sprained ankle or a paper cut. The pain is of short duration, but it gradually resolves as the injured tissues heal.
The intensity, quality, and duration of postoperative pain are affected mainly by location, type, and duration of the surgical procedure; type and extent of the incision and surgical trauma; the physical and mental state of the patient, including the patient's approach to pain; preoperative psychological and pharmacological preparation; type of anesthesia; pain management before and after the surgical procedure; incidence of surgical complications; and quality of postoperative care.
Specific evaluation of pain includes the location of the pain and its radiation, quality of the pain (dull, sharp, throbbing, shooting, burning, etc.), duration of the pain (constant, intermittent, paroxysmal), causative factors (movement, sitting position, cough, etc., the intensity of the pain at rest or during movement), accompanying symptoms, quality of sleep, assessment of the patient's expectations, personal approach to pain, stress, and pain coping strategies, analgesic therapy preferences.
Postoperative Pain Market Key Facts
• In 2022, the US captured the highest market share (85%), followed by Japan (7%), out of all the 7MM countries.
• The market size in the 7MM will increase at a CAGR of 7.2% due to an increase in surgical procedures being carried out and the launch of emerging therapies.
• Among EU4 countries, Germany accounted for the maximum market size in 2022, while Spain occupied the bottom of the ladder 2022.
• The total number of surgical procedures in the US was around 58,190,000 in 2022.
• In the US, approximately 91% of the surgical procedures were found to be from inpatient visits, whereas the remaining procedures were outpatient ones.
• The United States contributed to the largest number of incident cases of Postoperative Pain (~60%) in the 7MM in 2022. Whereas, EU4 and the UK, and Japan accounted for around 23% and 17% of the total incident cases in the 7MM, respectively, in 2022.
• Among the EU4 countries, Germany accounted for the largest number of surgical cases, followed by the UK, whereas Spain accounted for the lowest number of cases in 2022.
Postoperative Pain Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Postoperative Pain therapies in the market. It also provides a detailed assessment of the Postoperative Pain market drivers & barriers, unmet needs, and emerging technologies.
The report gives complete detail of the market trend for each marketed Postoperative Pain drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Discover How Postoperative Pain Market Will Grow by 2032:
https://www.delveinsight.com/report-store/postoperative-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Postoperative Pain Epidemiology
The epidemiology section covers detailed insights into the historical, and current Postoperative Pain patient pool and forecasted epidemiology trends for every seven major countries (7MM) from 2019 to 2032.
The Reports Cover the Head and Neck Cancer Epidemiology Segmented as -
• Total Number of Surgical Procedures (inpatient and outpatient) in the 7MM [2019-2032]
• Total Number of Incident Cases of Postoperative Pain in the 7MM [2019-2032]
• Severity-specific Incident Cases of Postoperative Pain in the 7MM [2019-2032]
Get Key Insights Into the Evolving Postoperative Pain Epidemiology Trends:
https://www.delveinsight.com/report-store/postoperative-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Postoperative Pain Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the Postoperative Pain market or expected to be launched during the study period. The analysis covers the market share by Postoperative Pain drugs, patient uptake by therapies, and sales of each drug.
The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It allows the comparison of the drugs based on market share and size, which again will be helpful in investigating factors important in understanding the market dynamics and in making financial and regulatory decisions.
The report also covers the Postoperative Pain Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Explore More About Ongoing Pipeline Development Activities:
https://www.delveinsight.com/sample-request/postoperative-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Postoperative Pain Therapeutics Assessment
The treatment pattern currently consists of different approaches, classified into pharmacologic and non-pharmacological therapies. The pharmacological therapies include analgesics that are further segregated into opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), cetaminophen, corticosteroids, anesthetics, etc. Acute pain is also managed by the use of benzodiazepines, muscle relaxants, antidepressants, alpha-2 agonists, gamma-aminobutyric agonists, and cannabinoids.
Several major pharma and biotech companies are developing therapies for Postoperative Pain. Currently, Vivozon Pharmaceutical Inc is leading the therapeutics market with its Postoperative Pain drug candidates in the most advanced stage of clinical development.
Leading Companies in the Postoperative Pain Therapeutics Market Include
• Allay Therapeutics
• Bexson Biomedical
• Concentric Analgesics
• Flexion Therapeutics
• Haisco Pharmaceutical Group
• InSitu Biologics
• Jiangsu HengRui Medicine Co., Ltd.
• LipoCure
• Nevakar, Inc.
• Oculis Pharma
• SiteOne Therapeutics
• Vivozon Pharmaceutical Inc.
And Many Others
Emerging and Marketed Postoperative Pain Therapies Covered in the Report Include
• CA-008: Concentric Analgesics
• DEXTENZA (dexamethasone): Ocular Therapeutix
• SVT-15473 (clobetasol propionate ophthalmic nanoemulsion 0.05%): Salvat Laboratories
• TLC590: Taiwan Liposome Company
• VVZ-149: Vivozon Pharmaceutical Inc.
• ZYNRELEF (bupivacaine and meloxicam): Heron Therapeutics
And Many More
Learn More About the Emerging Therapies & Key Companies in the Postoperative Pain Therapeutics Market:
https://www.delveinsight.com/sample-request/postoperative-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Postoperative Pain Competitive Intelligence Analysis
4. Postoperative Pain Market Overview at a Glance
5. Postoperative Pain Background and Overview
6. Postoperative Pain Patient Journey
7. Postoperative Pain Epidemiology and Patient Population
8. Postoperative Pain Treatment Algorithm, Current Treatment, and Medical Practices
9. Postoperative Pain Unmet Needs
10. Key Endpoints of Postoperative Pain Treatment
11. Postoperative Pain Marketed Products
12. Postoperative Pain Emerging Therapies
13. Postoperative Pain Seven Major Market Analysis
14. Attribute Analysis
15. Postoperative Pain Market Outlook (7 major markets)
16. Postoperative Pain Access and Reimbursement Overview
17. KOL Views on the Postoperative Pain Market.
18. Postoperative Pain Market Drivers
19. Postoperative Pain Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Download the Sample PDF to Get Detailed Insights About the Report's Offerings:
https://www.delveinsight.com/sample-request/postoperative-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight -
• Mucopolysaccharidosis I Market
https://www.delveinsight.com/report-store/mucopolysaccharidosis-i-market
• Ocular Melanoma Market
https://www.delveinsight.com/report-store/ocular-melanoma-market
• Orthostatic Hypotension Market
https://www.delveinsight.com/report-store/orthostatic-hypotension-market
• Osteochondrodysplasia Market
https://www.delveinsight.com/report-store/osteochondrodysplasia-market
• Pars Plantis Market
https://www.delveinsight.com/report-store/pars-plantis-market
• Point of Care Glucose Testing Market
https://www.delveinsight.com/report-store/point-of-care-glucose-testing-market
• Respiratory Distress Syndrome Market
https://www.delveinsight.com/report-store/respiratory-distress-syndrome-market
• Tendonitis Market
https://www.delveinsight.com/report-store/tendonitis-market
• Total Knee Arthroplasty Market
https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
• Trastuzumab Biosimilars
https://www.delveinsight.com/report-store/trastuzumab-biosimilars-insight
• Traveler's Diarrhea Market
https://www.delveinsight.com/report-store/travelers-diarrhea-market
• Usher Syndrome Market
https://www.delveinsight.com/report-store/usher-syndrome-market
• Varicose Veins Market
https://www.delveinsight.com/report-store/varicose-veins-market
• Vulvodynia Market
https://www.delveinsight.com/report-store/vulvodynia-market
• Wide Neck Bifurcation Intracranial Aneurysms Market
https://www.delveinsight.com/report-store/wide-neck-bifurcation-intracranial-aneurysms-market
Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Postoperative Pain Market to Expand at a Significant Growth Rate During the Study Period (2019-32) - Estimates DelveInsight | Concentric Analgesics, Oculis, Vivozon, Haisco, Nevakar, LipoCure, Bexson, SiteOne Therapeutics, InSitu Biologics here
News-ID: 3129528 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Postoperative
Postoperative Acute Pain Market Trends, Treatments, and Global Forecast
Postoperative acute pain (POAP) remains one of the most significant challenges in clinical care, affecting nearly 80% of patients after surgery. Poorly managed pain can lead to complications such as delayed recovery, prolonged hospital stays, readmissions, and higher healthcare costs. Traditionally, opioid analgesics have been the cornerstone of treatment, but rising concerns around opioid dependency and adverse effects are fueling demand for safer, multimodal pain management approaches.
Download Full PDF Sample…
Postoperative Pain Therapeutics Market Innovations and Trends for 2032
The Postoperative Pain Therapeutics market has become an essential sector within the healthcare industry, particularly in the wake of increasing surgical procedures and the subsequent need for effective pain management solutions. This market encompasses a wide range of therapeutics designed to alleviate pain following surgical interventions, ensuring patient comfort and satisfaction during recovery. With a focus on improving patient outcomes, the postoperative pain therapeutics market has seen significant advancements, driven…
Postoperative Pain Therapeutics Market Analysis and Forecast (2024-2032)
The introduction serves as the foundational section of our analysis. It aims to provide a comprehensive overview of the Postoperative Pain Therapeutics Market, emphasizing its significance and the purpose of the analysis.
The Postoperative Pain Therapeutics Market plays a pivotal role in the healthcare industry. It addresses the critical need for effective pain management following surgical procedures, contributing to patient comfort and recovery. This market has witnessed substantial growth due to…
Postoperative Nausea and Vomiting Management Market Rising focus on patient comf …
Global Postoperative Nausea and Vomiting Management Market Overview:
The Postoperative Nausea and Vomiting Management market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Postoperative Nausea and Vomiting Management market has experienced significant growth, driven by factors such as increasing consumer demand,…
Prevention and management of postoperative endophthalmitis
The decisive criterion of postoperative endophthalmitis after cataract operations or intravitreal injections is the contamination of the operating area and the instruments / implants with pathogens during the surgical procedure. In traditional operating theaters, the "sterility" is very limited and only given directly under the supply air ceiling. However, the surgical field is almost completely shielded from the ultra-clean air by the surgical microscope and the surgeon's head, so that…
Postoperative Pain Therapeutics Market Projections 2019 – 2027
Transparency Market Research (TMR) has published a new report, titled, ‘Postoperative Pain Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027′. According to the postoperative pain therapeutics market report, the global postoperative pain therapeutics market was valued at US$ 11,459.3 Mn in 2018, and is projected to expand at a CAGR of nearly 4.5% from 2019 to 2027. High incidence and severity of postoperative pain, introduction…
